Cindy Amundsen, MD
Urogynecology and Reconstructive Pelvic Surgery · Durham, NCNPI 1750464996
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,471 of the $18,716 with a category attached, or 98.7%. Every reported general payment came from a single manufacturer, Bluewind Medical.
Across 15 payments — averaging $1247.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bluewind Medical$19K
Across 87 payments — averaging $3494.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bluewind Medical$304K
What the payments were for
- Consulting fees$18,47199%
- Travel & lodging$2231%
- Food & beverage$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bluewind Medical | 15 | $18,716 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,716 in reported general payments places this provider in the 80th percentile of 35 urogynecology and reconstructive pelvic surgery providers in North Carolina.
See all urogynecology and reconstructive pelvic surgery providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 94 | $66,451 |
| GemtesaVibegron | 52 | $47,600 |
| Estradiol | 192 | $13,253 |
| PremarinEstrogens, Conjugated | 26 | $11,074 |
| Mirabegron ErMirabegron | 15 | $10,901 |
| Trospium Chloride ErTrospium Chloride | 33 | $6,122 |
| Methenamine Hippurate | 41 | $2,439 |
| Trimethoprim | 23 | $1,210 |
| Solifenacin Succinate | 13 | $430 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 26 | $311 |
| Cephalexin | 16 | $122 |
| Ciprofloxacin Hcl | 17 | $76 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $67 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Durham
- Nazema SiddiquiDurham$29K
- Amie KawasakiDurham$27K
- Ana MeekinsDurham$7K
- Cassandra KisbyDurham$2K
- Annika SinhaDurham$359
- Whitney Hendrickson-CahillDurham$132
- Cassandra ShawDurham$31
- Cary FishburneCharlotte$231K
- William PorterCharlotte$157K
- Catherine MatthewsWinston Salem$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.